Find Pyronaridine Tetraphosphate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as:
Molecular Formula
C29H44ClN5O18P4
Molecular Weight
910.0  g/mol
InChI Key
JDVZOLDKAQEQDD-UHFFFAOYSA-N

Pyronaridine Tetraphosphate
1 2D Structure

Pyronaridine Tetraphosphate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-[(7-chloro-2-methoxy-1,5-dihydrobenzo[b][1,5]naphthyridin-10-yl)imino]-2,6-bis(pyrrolidin-1-ylmethyl)cyclohexa-2,5-dien-1-one;phosphoric acid
2.1.2 InChI
InChI=1S/C29H32ClN5O2.4H3O4P/c1-37-26-9-8-24-28(33-26)27(23-7-6-21(30)16-25(23)32-24)31-22-14-19(17-34-10-2-3-11-34)29(36)20(15-22)18-35-12-4-5-13-35;4*1-5(2,3)4/h6-9,14-16,32-33H,2-5,10-13,17-18H2,1H3;4*(H3,1,2,3,4)
2.1.3 InChI Key
JDVZOLDKAQEQDD-UHFFFAOYSA-N
2.1.4 Canonical SMILES
COC1=CC=C2C(=C(C3=C(N2)C=C(C=C3)Cl)N=C4C=C(C(=O)C(=C4)CN5CCCC5)CN6CCCC6)N1.OP(=O)(O)O.OP(=O)(O)O.OP(=O)(O)O.OP(=O)(O)O
2.1.5 Isomeric SMILES
COC1=CC=C2C(=C(C3=C(N2)C=C(C=C3)Cl)N=C4C=C(C(=O)C(=C4)CN5CCCC5)CN6CCCC6)N1.OP(=O)(O)O.OP(=O)(O)O.OP(=O)(O)O.OP(=O)(O)O
2.2 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 910.0 g/mol
Molecular Formula C29H44ClN5O18P4
Hydrogen Bond Donor Count14
Hydrogen Bond Acceptor Count23
Rotatable Bond Count6
Exact Mass909.1320353 g/mol
Monoisotopic Mass909.1320353 g/mol
Topological Polar Surface Area380 A^2
Heavy Atom Count57
Formal Charge0
Complexity1130
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count5

API SUPPLIERS

read-more
read-more

01

Mangalam Drugs & Organics Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health
Not Confirmed
arrow

Mangalam Drugs & Organics Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
USDMF CEP/COS JDMF EU-WCInactive-api NDC KDMF VMF Others AUDIT
blank

02

Sibbiotech

Russia

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health
Not Confirmed
arrow
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"PYRONARIDINE TETRAPHOSPHATE","year":"2021","qtr":"Q1","strtotime":1615401000,"product":"BULK DRUG: PYRONARIDINE TETRAPHOSPHATE","address":"292 PRINCESS STREET2ND FLOOR","city":"MUMBAI ,MAHARASHTRA","supplier":"MANGALAM DRUGS & ORGANICS LTD","supplierCountry":"INDIA","foreign_port":"KARACHI -","customer":"OF","customerCountry":"PAKISTAN","quantity":"1.30","actualQuantity":"1.3","unit":"KGS","unitRateFc":"1357.7","totalValueFC":"1746.8","currency":"USD","unitRateINR":97822.715384615381,"date":"11-Mar-2021","totalValueINR":"127169.53","totalValueInUsd":"1746.8","indian_port":"BOMBAY AIR","hs_no":"29333911","bill_no":"9277414","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"292 PRINCESS STREET2ND FLOOR, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1677868200,"product":"BULK DRUG : PYRONARIDINE TETRAPHOSPHATE","address":"3RD FLOOR, RUPAM BUILDING, 239,P. D. MELLO ROAD, NEAR G.P.O.","city":"MUMBAI,MAHARASHTRA","supplier":"MANGALAM DRUGS & ORGANICS LTD","supplierCountry":"INDIA","foreign_port":"SHANGHAI","customer":"TO THE ORDER OF","customerCountry":"CHINA","quantity":"7.00","actualQuantity":"7","unit":"KGS","unitRateFc":"1000","totalValueFC":"6759.8","currency":"USD","unitRateINR":79428.571428571435,"date":"04-Mar-2023","totalValueINR":"556000","totalValueInUsd":"6759.8","indian_port":"BOMBAY AIR","hs_no":"29333911","bill_no":"8247925","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"3RD FLOOR, RUPAM BUILDING, 239,P. D. MELLO ROAD, NEAR G.P.O., MUMBAI,MAHARASHTRA","customerAddress":""}]
11-Mar-2021
04-Mar-2023
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

read-more
read-more

Details:

The grant will support research and development efforts aimed at improving the technology and efficiency of pyronaridine production for pyronaridine-artesunate combination therapy, Pyramax.


Lead Product(s): Pyronaridine Tetraphosphate,Artesunate

Therapeutic Area: Infections and Infectious Diseases Brand Name: Pyramax

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Medicines for Malaria Venture

Deal Size: $0.2 million Upfront Cash: Undisclosed

Deal Type: Funding August 27, 2024

blank

01

CPHI Middle east
Not Confirmed
CPHI Middle east
Not Confirmed

Details : The grant will support research and development efforts aimed at improving the technology and efficiency of pyronaridine production for pyronaridine-artesunate combination therapy, Pyramax.

Brand Name : Pyramax

Molecule Type : Small molecule

Upfront Cash : Undisclosed

August 27, 2024

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty